Xience Sierra Stent Mri Safety. Xience Sierra Everolimus Eluting Coronary Stent Abbott Vascular The design of XIENCE Sierra™ Stent is unlike that of other drug-eluting stents (DES) Formal drug interaction studies have not been performed with the XIENCE Skypoint™, XIENCE Sierra™ or XIENCE Alpine™ Stent Systems because of limited exposure to everolimus eluted from XIENCE Skypoint™, XIENCE Sierra™ and XIENCE Alpine™ Stent Systems
New ABBOTT 155040012 Xience Sierra Everolimus Eluting Coronary Stent from www.dotmed.com
A patient with this device can be safely scanned in an MR system under the following conditions: Everolimus, the active ingredient in the stents, is an immunosuppressive agent.
New ABBOTT 155040012 Xience Sierra Everolimus Eluting Coronary Stent
Drug-eluting coronary artery stent, non-bioabsorbable-polymer-coated MRI at 1.5 or 3 Tesla may be performed immediately following the implantation of the XIENCE V® stent. Non-clinical testing has demonstrated that the XIENCE Sierra stent, in single and in overlapped configurations up to 71 mm in length, is MR Conditional
Abbott 155025038 Vascular XIENCE Sierra Coronary Stnt System 2.5mm x. What MRI safety information does the labeling contain? MR. Non-clinical testing has demonstrated that the XIENCE Sierra stent, in single and in overlapped configurations up to 71 mm in length, is MR Conditional
XIENCE Stent Fluoropolymer Enhances Safety Abbott. XIENCE Sierra™ Stent Even When Patients Are Complex— Choosing a Stent Shouldn't Be Push efficiency comparison is between XIENCE Skypoint™ Stent, XIENCE Xpedition™ Stent, and Synergy ‡ - 3.0 x 48 mm for all stents tested